Characterisation of microRNA expression in post-natal mouse mammary gland development by Avril-Sassen, Stefanie et al.
BioMed  Central
Page 1 of 15
(page number not for citation purposes)
BMC Genomics
Open Access Research article
Characterisation of microRNA expression in post-natal mouse 
mammary gland development
Stefanie Avril-Sassen†1,7, Leonard D Goldstein†2,5, John Stingl3,6, 
Cherie Blenkiron4, John Le Quesne1, Inmaculada Spiteri1, 
Konstantina Karagavriilidou1, Christine J Watson6, Simon Tavaré2,5, 
Eric A Miska*4 and Carlos Caldas*1
Address: 1Breast Cancer Functional Genomics Laboratory, Cancer Research UK Cambridge Research Institute and Department of Oncology, 
University of Cambridge, Li Ka Shing Centre, Cambridge, UK, 2Computational Biology Group, Cancer Research UK Cambridge Research Institute 
and Department of Oncology, University of Cambridge, Li Ka Shing Centre, Cambridge, UK, 3Mammary Stem Cell Biology Group, Cancer 
Research UK Cambridge Research Institute, Li Ka Shing Centre, Cambridge, UK, 4Wellcome Trust/Cancer Research UK Gurdon Institute and 
Department of Biochemistry, University of Cambridge, Cambridge, UK, 5Computational Biology Group, Department of Applied Mathematics and 
Theoretical Physics, University of Cambridge, Cambridge, UK, 6Department of Pathology, University of Cambridge, Cambridge, UK and 7Current 
address: Department of Pathology, Technische Universität München, Munich, Germany
Email: Stefanie Avril-Sassen - stefanie.avril@lrz.tum.de; Leonard D Goldstein - ldg21@cam.ac.uk; John Stingl - john.stingl@cancer.org.uk; 
Cherie Blenkiron - cb391@cam.ac.uk; John Le Quesne - john.lequesne@cancer.org.uk; Inmaculada Spiteri - inma.spiteri@cancer.org.uk; 
Konstantina Karagavriilidou - kk406@cam.ac.uk; Christine J Watson - cjw53@mole.bio.cam.ac.uk; Simon Tavaré - simon.tavare@cancer.org.uk; 
Eric A Miska* - e.miska@gurdon.cam.ac.uk; Carlos Caldas* - carlos.caldas@cancer.org.uk
* Corresponding authors    †Equal contributors
Abstract
Background: The differential expression pattern of microRNAs (miRNAs) during mammary gland development might
provide insights into their role in regulating the homeostasis of the mammary epithelium. Our aim was to analyse these
regulatory functions by deriving a comprehensive tissue-specific combined miRNA and mRNA expression profile of post-
natal mouse mammary gland development.
We measured the expression of 318 individual murine miRNAs by bead-based flow-cytometric profiling of whole mouse
mammary glands throughout a 16-point developmental time course, including juvenile, puberty, mature virgin, gestation,
lactation, and involution stages. In parallel whole-genome mRNA expression data were obtained.
Results: One third (n = 102) of all murine miRNAs analysed were detected during mammary gland development.
MicroRNAs were represented in seven temporally co-expressed clusters, which were enriched for both miRNAs
belonging to the same family and breast cancer-associated miRNAs. Global miRNA and mRNA expression was
significantly reduced during lactation and the early stages of involution after weaning. For most detected miRNA families
we did not observe systematic changes in the expression of predicted targets. For miRNA families whose targets did
show changes, we observed inverse patterns of miRNA and target expression. The data sets are made publicly available
and the combined expression profiles represent an important community resource for mammary gland biology research.
Conclusion: MicroRNAs were expressed in likely co-regulated clusters during mammary gland development. Breast
cancer-associated miRNAs were significantly enriched in these clusters. The mechanism and functional consequences of
this miRNA co-regulation provide new avenues for research into mammary gland biology and generate candidates for
functional validation.
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Background
MicroRNAs (miRNAs) are a class of small non-coding
RNA, approximately 23 nucleotides in length, which reg-
ulate gene expression post-transcriptionally and play a key
role in development and specific biological processes such
as cell proliferation, differentiation, and apoptosis [1-3].
MicroRNAs regulate their target genes through direct deg-
radation of the messenger RNA (mRNA) and/or transla-
tional inhibition [4-7]. While subsets of miRNAs are
specifically expressed during early mammalian develop-
ment [8], others are essential for morphogenesis of partic-
ular organs, such as brain [9] or heart [10], or
hematopoietic differentiation [11,12]. In specific mam-
malian cell types or organs single tissue-specific miRNAs
have been identified [13,14]. There is little information
available regarding miRNA expression in the mammary
gland. In human breast tissue, 23 miRNAs (out of 161
studied) were identified by microarray analysis [15] and 9
miRNAs (out of 22) were detected in mouse mammary
gland by northern blot [16].
Mammary gland development in both humans and mice
is predominantly a post-natal process (Figure 1a). At
birth, rudimentary mammary ducts are present, derived
from the ectodermal mammary placode. Ovarian and
pituitary hormones induce ductal outgrowth and branch-
ing during puberty, at about three to six weeks of age in
mice, followed by alveolar differentiation during gesta-
tion and full functional differentiation upon parturition
and lactation. After weaning, the entire alveolar compart-
ment is remodelled to resemble a virgin-like state. Each
gestation initiates a new round of lobulo-alveolar differ-
entiation [17,18]. These morphologic changes are illus-
trated in Figure 1d. Our aim was to study the pattern and
temporal changes of miRNA expression during mouse
mammary gland development. In parallel, gene expres-
sion data were obtained to provide another view of the
underlying biological processes at the mRNA level.
Altered miRNA expression has been implicated in various
human diseases including cancer [19]. In human breast
cancer, complex de-regulated miRNA expression patterns
have been described [20-23]. The expression of 29 miR-
NAs was significantly different between human normal
breast tissue and breast cancer [21], and a panel of 38
miRNAs was found to be differentially expressed between
molecular subtypes of breast cancer, namely Luminal A,
Luminal B, Her-2 positive, Basal-like, and Normal-like
breast cancers [20]. This suggests that miRNAs might play
a role in regulating the homeostasis of the mammary epi-
thelial hierarchy and their disruption could therefore con-
tribute to tumourigenesis.
The mammary gland is unique in its capability to undergo
cycles of cell proliferation, differentiation, and apoptosis
during adult life. More importantly, the mammary epithe-
lium invades the stroma during mammary gland develop-
ment in a process similar to that of cancer. Therefore we
investigated the miRNA expression pattern during mam-
mary gland development to provide the basis for compar-
isons with breast cancer profiles and for selection of
representative miRNA candidates for future functional
characterization in breast development and breast cancer.
Results
mRNA expression during mammary gland development
Our use of whole glands (after carefully removing the
mammary lymph node) for RNA isolation could raise
questions as to whether the expression changes reflect epi-
thelial-driven biological processes. To gain an overview of
changes in mRNA expression between different develop-
mental stages we assessed the activity of biological proc-
esses and pathways as determined by the mean relative
expression of genes belonging to the same Gene Ontology
term or KEGG pathway (Figure 1b, c). In accordance with
previous reports, we found that most developmental
stages were dominated by a few biological processes and
pathways which are known to be involved in regulating
mammary epithelial biology. For example during puberty
and gestation, proliferation and associated processes of
cell division and mitosis were highly represented, cal-
cium/sodium ion transport, translation and intracellular
protein transport were prominent during lactation, apop-
tosis dominated during early involution and inflamma-
tory/immune response was dominant during late
involution (Figure 1b). We further assessed the propor-
tion of luminal, basal, and stromal cells at eight develop-
mental time points up to mid-gestation by fluorescence-
activated cell sorting (FACS) of dissociated total mouse
mammary glands. The proportion of stromal cells, which
comprised up to 90% of the whole gland in juvenile
stages, gradually declined until puberty, staying relatively
constant thereafter comprising 65%-75% of the mam-
mary gland. The proportion of luminal cells showed an
increase before the onset of puberty with a peak at mid-
puberty, followed by a slow decrease during gestation.
Basal cells showed a slow and steady increase after the
onset of puberty (Additional file 1). Expression levels of
luminal (Krt18) and basal (Krt14) cytokeratins reflected
the changes in the epithelial compartment (Additional
file 2). Although stromal cells contribute significant num-
bers of cells to the mammary gland, the mRNA expression
data show that the observed differential gene expression
mostly reflected mammary epithelium-driven processes.
This also suggests the observed miRNA differential expres-
sion is mostly associated with mammary epithelium-
driven events.BMC Genomics 2009, 10:548 http://www.biomedcentral.com/1471-2164/10/548
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Normal development of the mouse mammary gland Figure 1
Normal development of the mouse mammary gland. (a) Schematic of distinct stages of development and characteristic 
biological processes. Shown are time points used for mRNA expression profiling (time point 12 hours involution was used for 
miRNA expression profiling only, time points 8 weeks and 10 days lactation were used for mRNA expression profiling only). 
(b-c) Mean relative log2 mRNA expression for non-redundant Gene Ontology biological processes (b) and KEGG pathways (c) 
(shown are gene sets with at least 100 genes represented on the array, numbers of genes are indicated in brackets). Red and 
blue indicate high and low relative log2 expression, respectively. (d) Representative H&E stained histological sections of mouse 
mammary glands obtained at distinct time points during development and used for expression analysis.BMC Genomics 2009, 10:548 http://www.biomedcentral.com/1471-2164/10/548
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MicroRNA expression profiles distinguish the stages of 
mammary gland development
Out of 318 unique murine miRNAs analysed, 102 miR-
NAs were detected above background in one or more
developmental time points. The majority of miRNAs were
expressed intermittently throughout development and
were not present in one or more developmental stages. We
first asked whether the global miRNA expression profiles
of time points would allow us to separate developmental
stages. Unsupervised hierarchical clustering of time points
based on relative miRNA expression resulted in a clear
separation of developmental stages, with close clustering
of time points with chronological or functional depend-
ence (Figure 2a). The early juvenile time points (12, 15,
19, 25 days) clustered together, as did the consecutive
stages puberty (6 weeks), mature virgin (10 weeks), and
early gestation (gestational day 5). Lactation and the early
stages of involution (between 12 and 48 hours after wean-
ing) clustered together and were clearly separated from
the cluster of late involution stages, between 4 and 6 days
after weaning. Profiles based on the expression of 102
miRNAs thus distinguished distinct stages of mammary
gland development in a similar manner to mRNA expres-
sion signatures (Additional file 3).
Global decrease in miRNA and mRNA expression during 
lactation and early involution
During lactation and the early stages of involution (12, 24
and 48 hours after weaning) we observed an approxi-
mately two-fold reduction in mean miRNA expression (P
< 0.01, two-sided Wilcoxon rank sum test; Figure 2b). In
contrast, overall miRNA expression was increased approx-
imately two-fold during the late stages of involution (4, 5
and 6 days after weaning) as compared to earlier develop-
mental time points (P < 0.01, two-sided Wilcoxon rank
sum test). No obvious differences in global miRNA
expression were detected between the remaining time
points, including juvenile, virgin, and gestation stages
(Figure 2b). A similar decrease was observed for the
number of miRNAs present at a given time point. During
lactation and early involution, an average of 47 individual
miRNAs were detected at each time point (range 38 to
56), compared to an average of 70 miRNAs present at
other time points during development (range 55 to 87).
Global changes in miRNA and mRNA expression Figure 2
Global changes in miRNA and mRNA expression. (a) Hierarchical clustering of time points based on the relative log2 
expression of 102 detected miRNAs. (b) miRNAs and mRNAs exhibit reduced overall expression during lactation and early 
involution time points. Black dots correspond to independent biological replicates. Median values for each time point are con-
nected by a solid black line. (Top) miRNA expression. Normalised log2 median fluorescence intensity (MFI) values (see Meth-
ods) were averaged for each sample by taking the arithmetic mean. (Middle) mRNA expression. The background corrected 
Illumina probe level data were transformed by taking logs (base 2) but no between sample normalisation was performed. Non-
normalised log2 intensities were averaged for each sample by taking the arithmetic mean. (Bottom) Mass of total RNA 
extracted from whole mammary glands, and equally sized partial glands for lactation and involution time points.
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Changes in miRNA expression during lactation and early
involution were paralleled by a decrease in mean mRNA
expression as assessed by non-normalised microarray
expression data (P < 0.05, two-sided Wilcoxon rank sum
test). In contrast to the decrease in miRNA and mRNA
expression during lactation and early involution, we
observed a dramatic increase in the total RNA content per
mammary gland for these time points (Figure 2b).
MicroRNAs are expressed in seven distinct temporal 
clusters during development
We next aimed to identify groups of miRNAs with similar
relative expression patterns over the course of mammary
gland development. Model-based clustering [24] identi-
fied seven clusters with distinct temporal expression pro-
files (Figure 3), and most individual miRNA profiles were
assigned to one of the seven clusters with high certainty
(84 with certainty > 0.99, minimum certainty 0.76).
The three largest clusters (clusters 1-3) showed a decrease
in miRNA expression during lactation and early involu-
tion, but differed in their typical expression at earlier time
points. While many miRNAs in cluster 1, including six
members of the let-7 family, showed high expression dur-
ing puberty (six weeks), maturity (ten weeks) and early
gestation (five days), members of cluster 2 frequently
peaked in their expression before puberty (19 days) and
during late gestation (15 days). Cluster 3 miRNAs gener-
ally showed a monotone increase in expression over time,
reaching maximum expression in late gestation (15 days).
In stark contrast to the typical pattern of reduced miRNA
expression during lactation and early involution, cluster 4
showed highest expression during these stages of develop-
ment. This cluster included the seed-identical miRNAs
miR-141 and miR-200a, and miR-429, which is situated
in the same genomic cluster as miR-200a. It further
included miR-146b, miR-210 and multiple members of
the miR-148 and miR-181 families. Clusters 5 and 6
exhibited very distinct profiles, with the former being
highly expressed exclusively in early development. Cluster
6, containing the miR-1/206 and miR-133 family, showed
a distinct peak of expression during late involution,
between 4 and 6 days after weaning, as well as a second
smaller peak during early development from 12 to 15 days
of age. The five miRNAs temporally co-expressed in this
expression cluster are also clustered in the genome (at two
distinct loci on chromosomes 1 and 18). The profile of
cluster 7, including miR-196a/b and miR-203, showed an
inverse pattern to cluster 4, with high expression in early
development and gestation followed by low expression in
lactation and involution stages.
miRNAs in the same cluster often shared identical seed
sequences (indicated by brackets in the right-hand margin
of Figure 3b) and thus likely share common mRNA tar-
gets. An analysis of biological processes and pathways
enriched or depleted among predicted cluster targets is
given in Additional file 4. We also observed genomic clus-
tering of many co-expressed miRNAs (Additional file 5),
suggesting polycistronic transcription.
Breast cancer-associated miRNAs during mammary gland 
development
We next assessed whether orthologs of the miRNAs that
had previously been associated with various clinicopatho-
logic and molecular parameters of human breast cancer
were represented within the seven temporal clusters of
miRNAs during mammary gland development. The selec-
tion of breast cancer-associated miRNAs was based on
data that we previously reported [20] (see Methods).
Interestingly, miRNAs with increased expression in lumi-
nal as compared to basal breast cancers (see Methods)
were often co-expressed during development, and strik-
ingly enriched in cluster 1 (P < 0.001, two-sided Fisher's
exact test), with 14 out of 21 miRNAs identified as highly
expressed in luminal breast cancers representing more
than 40% of cluster 1 miRNAs. In contrast, miRNAs over-
expressed in the basal breast cancer subtype (four mem-
bers of the miR-17~92 family, miR-25 and miR-150) were
distributed equally among clusters 1 and 2 (Figure 3b).
MicroRNA expression in distinct cell types assessed by in-
situ hybridisation
To further assess cellular origin of miRNA expression, we
analysed representative miRNAs from three out of the
seven clusters by in-situ hybridisation (Figure 4 and Addi-
tional file 6). There was generally much higher expression
of all miRNAs analysed in the epithelial cells compared to
the stroma. The background signal from stromal tissue
showed high variability between different probes, and a
random pattern of staining. Although this suggests non-
specific binding in the stroma, weak miRNA expression
cannot be excluded. The strongest background staining of
stromal tissue was found in the developmental stages of
lactation and involution.
Overall, there was good agreement between expression
patterns found by in-situ hybridisation and by microar-
ray. Two miRNAs, namely let-7b and miR-205, showed
specificity for the luminal and basal epithelial cell layers,
respectively, during juvenile, puberty, and mature virgin
stages. For let-7b (cluster 1), luminal expression was lost
during pregnancy, lactation and early involution, and
expression recurred in both luminal and basal epithelium
in late involution. miR-205 (cluster 3) was strongly
expressed in the basal epithelium until the mature virgin
stage, showing increased expression in both luminal and
basal epithelium during pregnancy and in late involution.
miR-206 (cluster 6) showed increasing expression duringBMC Genomics 2009, 10:548 http://www.biomedcentral.com/1471-2164/10/548
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miRNA expression during mammopoiesis is highly correlated Figure 3
miRNA expression during mammopoiesis is highly correlated. Seven clusters obtained by model-based clustering are 
displayed in separate panels. (a) Grey lines represent the standardized log2 expression profiles of individual miRNAs. Black lines 
correspond to mean cluster profiles. (b) Heatmaps of individual clustered miRNAs. Red and blue indicate high and low stand-
ardized log2 expression, respectively. Within each cluster panel, miRNAs are ordered according to miRNA families with identi-
cal seed sequence (position 2-8) (indicated by brackets). miRNAs associated with basal or luminal breast cancer are highlighted 
in red and blue, respectively. Individual panels correspond to the seven clusters in (a).
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late involution, in accordance with the microarray data.
Weak expression compared to background was present in
juvenile and gestational time points, which was more pro-
nounced in the microarray data. Detailed in-situ images
for all developmental stages are shown in Figure 4.
Altered expression of miRNA target genes during 
mammary gland development
To investigate systematic and specific changes in the
expression of miRNA targets, the 102 detected miRNAs
were grouped in families with unique seed sequence
(nucleotides 2-8) and 3' UTRs of genes with available
expression data were scanned for seed matches to identify
putative targets [25-29]. For each of these miRNA families
and each developmental time point, we tested whether
the mean relative expression of putative targets was higher
or lower than that of cohorts of control genes with similar
3' UTR features (see Methods). For most miRNA families
we did not detect any significant changes (Additional file
7). Figure 5 shows results for the miR-29 family, which
showed greatest evidence for changes in the expression of
predicted targets (P < 0.05 after Benjamini-Hochberg cor-
rection). Low relative expression of miR-29 during early
development and high expression during late involution
were paralleled by increased and reduced relative expres-
sion of seed match-harbouring transcripts, respectively.
Among putative miR-29 targets genes related to focal
adhesion were significantly overrepresented (Additional
file 4).
Discussion
Our data show that miRNAs are highly co-regulated dur-
ing mammary gland development. We found seven tem-
poral clusters with complex expression patterns which did
not coincide with single developmental stages. Breast can-
cer-associated miRNAs were found predominantly in two
of these clusters.
MicroRNAs previously identified to be highly expressed in
the luminal as compared to the basal molecular subtype
of breast cancer [20] were enriched in cluster 1. These
miRNAs showed high levels during puberty and gestation
where proliferation and invasion are the predominating
biological processes. We hypothesize that these luminal
breast cancer miRNAs may be involved in the control of
proliferation and invasion during normal development
and become deregulated in breast cancer. MicroRNAs
associated with the basal breast cancer subtype, including
four members of the miR-17~92 family, miR-25 and miR-
150, showed a distinctly different pattern, being equally
distributed among clusters 1 and 2.
Of particular interest was cluster 4, which in contrast to
the global decrease in miRNA expression during lactation
and involution showed a specific increase in expression
during these stages, paralleled by a decrease in the expres-
sion of predicted targets for one of the cluster members,
miR-429 (Additional file 7). The miRNAs included in this
cluster have previously been associated with various bio-
In-situ hybridisation for miRNAs let-7b (cluster 1), miR-205 (cluster 3), and miR-206 (cluster 6) shows higher expression in the  epithelial compared to the stromal cell compartment Figure 4
In-situ hybridisation for miRNAs let-7b (cluster 1), miR-205 (cluster 3), and miR-206 (cluster 6) shows higher 
expression in the epithelial compared to the stromal cell compartment. let-7b and miR-205 show specificity for the 
luminal and basal epithelial cell layers, respectively. White scale bars in images for time point 25d indicate 100 microns. Higher 
magnification images are provided in Additional file 6.BMC Genomics 2009, 10:548 http://www.biomedcentral.com/1471-2164/10/548
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logical functions and pathways. The cluster includes miR-
200 family members miR-200a, miR-141 and miR-429.
There is increasing evidence that this miRNA family plays
a crucial role in the regulation of epithelial to mesenchy-
mal transition (EMT). All five members of the miR-200
family were markedly down-regulated in cells that had
undergone EMT in response to transforming growth factor
(TGF)-beta [30]. Enforced expression of the miR-200 fam-
ily was sufficient to prevent TGF-beta induced EMT, while
inhibition of the miR-200 family was sufficient to induce
EMT in cells [30]. During mammary gland development,
a process similar to EMT is known to occur between lacta-
tion and involution. The loss of inter-epithelial cell-cell-
contacts, including loss of the cell-adhesion molecule E-
cadherin, takes place during the early reversible phase of
involution [31]. It is therefore tempting to speculate that
the miR-200 family may act to prevent premature loss of
E-cadherin and induction of EMT during lactation.
Another miRNA highly expressed during lactation and
early involution, miR-146b, has been associated with the
regulation of innate immune response and inflammation.
miR-146a expression has been reported to be substan-
tially increased in murine T helper (Th) 1 cells compared
to Th2 cells and naïve T cells [32]. The Th1 and Th2
cytokine milieu has recently been implicated in mouse
mammary gland development. Mammary epithelial cells
were demonstrated to undergo a switch from Th1 to Th2
cytokine production upon the induction of luminal differ-
entiation [33]. It is an intriguing possibility that miR-146
might be involved in abrogating the Th2 bias in cytokine
expression that continues during gestation and lactation,
to facilitate a switch back to a Th1 environment upon
involution.
Of note, we did not detect obvious changes in the miRNA
expression pattern between the stages of lactation and
early involution in our data, although there are known
morphological and transcriptional changes [34-37]. This
contrasts with what we observed at the level of mRNA
expression, where we could see clear differences between
the two stages (Figure 1b, c). Subtle differences in miRNA
expression between lactation and early involution may
have potentially been masked by the global decrease in
miRNA expression we observed during these stages.
We identified a significant global down-regulation of
miRNAs and mRNAs during the stages of lactation and
early involution. The total RNA content per mammary
gland was increased during these stages. Since our analysis
of miRNA expression was performed in equal amounts of
total RNA, this finding suggests that miRNAs and mRNAs
represented a smaller fraction of total RNA during lacta-
tion and early involution. We hypothesize that the up-reg-
ulation of the transcriptional and translational machinery
during milk production (with corresponding increases in
tRNAs/rRNAs) may lead to a relative rather than absolute
depletion of miRNAs during these developmental stages.
During mouse mammary gland development we
observed that many let-7 family members showed a peak
in expression during puberty, the mature virgin stage, and
early gestation, followed by a marked decrease and low
levels during lactation and involution. This observation is
consistent with recent reports that let-7 expression is
depleted in mouse mammary epithelial progenitors [38]
and in breast tumour-initiating cells [39], and that
enforced let-7 expression could inhibit the self-renewal
capacities of cells [38,39]. The developmental stages of the
juvenile gland, puberty, and early gestation, where we
detected increasing levels of let-7, are characterised by a
marked expansion of the luminal and alveolar cell com-
partment which presumably contains a high frequency of
relatively differentiated cells. The subsequent decrease in
let-7 expression during lactation may allow for a relative
expansion of the progenitor compartment which is neces-
sary for the reconstitution of the alveolar compartment
during the next pregnancy cycle. On the other hand, miR-
22 and miR-205, which were reported to be highly
expressed in mammary progenitor cells [38], seemed to be
enriched during gestation and again during late involu-
Predicted targets for the miR-29 family show systematic  changes in their relative expression Figure 5
Predicted targets for the miR-29 family show system-
atic changes in their relative expression. (Top) Relative 
log2 expression profiles of individual miR-29 family members 
are shown in distinct colours. (Bottom) Negative Log10 trans-
formed two-sided P-values are shown for each time point. 
The positive and negative y-axes indicate increased and 
reduced mean relative expression levels compared to con-
trol genes, respectively. Dashed lines indicate the threshold 
for Benjamini-Hochberg corrected P-values smaller than 
0.05.
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tion. These data suggest that miRNAs may contribute to
the balance between progenitor cells and their differenti-
ated progeny during mammary gland development.
When interpreting changes in miRNA expression during
mammary gland development, changes in the cellular
composition of the mammary gland have to be taken into
consideration. We observed that the proportion of stro-
mal cells gradually declined until puberty. Epithelial and
in particular luminal cells showed a peak at puberty fol-
lowed by a decrease, which was reflected in gene expres-
sion patterns, such as those of luminal and basal
cytokeratins. Nevertheless, the variety of biological proc-
esses and pathways and their observed temporal expres-
sion pattern (Figure 1b, c) cannot be solely explained by
changes in the cellular composition. Although stromal
cells contribute significant numbers of cells to the mam-
mary gland, our mRNA expression data show that the
observed differential gene expression mostly reflected
mammary epithelium-driven processes, and therefore we
infer that changes in miRNA expression are also predom-
inantly epithelial-driven. We were not able to demon-
strate by microarray analysis a clear correlation between
the expression of a particular miRNA and a predominat-
ing cell type. It is an inherent limitation of this study that
the impact of cell type heterogeneity on relative expres-
sion patterns obtained from whole mammary glands can-
not be conclusively assessed. Future analysis of isolated
cell populations may help to address this question, and
newer technologies for miRNA profiling which have
become available in the meantime allow the analysis of
smaller numbers of cells. Nevertheless, our analysis of
three candidate miRNAs by in-situ hybridisation gives
some indication of cell type specific expression in mam-
mary epithelial cells. MicroRNA expression was generally
much higher in epithelial cells compared to the stroma,
suggesting that the expression patterns found by microar-
ray mostly reflect temporal changes in the epithelial cell
compartment. Within the epithelial compartment, cell
type-specific expression was demonstrated for let-7 and
miR-205, which were predominantly expressed in lumi-
nal and basal cells, respectively, confirming previous
reports of their expression in human luminal and basal
breast epithelium [40].
It was shown previously that miRNAs and their targets
often exhibit mutually exclusive expression both in the
spatial and temporal domain [41], and that conserved tar-
gets and miRNAs are co-expressed but with reduced rela-
tive target expression in the presence of the miRNA [7].
We failed to detect widespread systematic changes in the
relative expression of putative targets during mammary
gland development. However, we did observe trends for
individual miRNA families (Additional file 7), most nota-
bly the miR-29 family, for which miRNAs and targets
showed anti-correlated expression (Figure 5). These
observations are consistent with miRNAs affecting mRNA
expression levels [7,42]. The down-regulation of miR-29
targets, enriched for focal adhesion genes, would fit with
the extensive remodelling and changes during late involu-
tion. Future analysis of isolated cell populations will fur-
ther contribute to investigations of the relationship
between miRNAs and their targets.
Conclusion
We expect that this first comprehensive data set of miRNA
and mRNA gene expression during mammary gland
development will provide an important resource for the
future functional characterisation of individual miRNAs
and their targets in mammary epithelial cells. Indeed with
our current understanding of miRNA target recognition
(see [43] for a recent review) combined data sets such as
the one presented here represent important resources that
will have increasing value as data integration methods
improve. It is likely that with further functional experi-
mentation new miRNA target-recognition rules will be
uncovered and these data will also be an important func-
tional genomics resource for their biological validation.
Methods
Mammary gland samples
Tissue collection
Six- to ten-week old female C57Bl/6 mice were obtained
from Charles River Laboratories (Margate, UK) and either
culled for virgin mammary glands or mated at 10 weeks of
age. For involution time points females were force weaned
at 10 days of lactation. Pups were culled at the specified
age for juvenile time points. Tissue was always collected at
the same time of day to account for circadian effects.
Mammary glands of the following six key developmental
stages, including 18 time points, were harvested: juvenile
(12, 15, 19, and 25 days of age), puberty (6 weeks of age),
mature virgin (8, 10 weeks of age), gestation (gestational
day 5, 10, and 15), lactation (day 5, 10 post partum), early
involution (12 h, 24 h, 48 h after weaning), and late invo-
lution (4 d, 5 d, and 6 d after weaning). A total of 2 to 3
animals, designated biological replicates, were used per
time point. In each case one complete inguinal gland was
removed following excision of the intra-mammary lymph
node and frozen in liquid nitrogen within 30 seconds
after tissue dissection. The contralateral abdominal glands
of each animal were immediately fixed in 4% formalde-
hyde overnight and embedded in paraffin according to
standard procedures for morphological analysis. Frozen
samples were stored at -80°C and paraffin embedded
samples were stored at room temperature, for 1 to 10
months until further analysis. Whole mounts of mam-
mary glands were prepared for time points until late ges-
tation using Carnoy's fixative and Carmine Alum stain, to
allow for a three-dimensional visualization of mammaryBMC Genomics 2009, 10:548 http://www.biomedcentral.com/1471-2164/10/548
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ducts and lobules. All experimental research on animals
was carried out according to UK Home Office regulations.
RNA extraction
Frozen tissue samples were homogenized in Trizol reagent
(Invitrogen, Carlsbad, CA, USA) with a polytron tissue
homogenizer, using a whole mammary gland per sample
for juvenile, virgin, and gestational time points, and
equally sized partial glands for lactation and involution
time points. After pre-spinning homogenized samples at
10,000 rpm at 4°C for 10 minutes to remove fat and cell
debris, total RNA was extracted from the supernatant
according to the manufacturer's protocol (Invitrogen,
Carlsbad, CA, USA), modified by washing the final RNA
pellet in 80% ethanol. RNA quantity and integrity were
confirmed with a NanoDrop spectrophotometer (Nano-
Drop Technologies, Wilmington, DE, USA) and Agilent
2100 bioanalyser (Agilent Technologies, Santa Clara, CA).
Only samples with an RNA integrity number ≥ 7 were
used for further miRNA expression analysis, and only
samples with an RNA integrity number ≥ 8 were used for
gene (mRNA) expression analysis.
Analysis of cellular composition of mammary glands
Flow cytometry was used to analyse the cellular composi-
tion of mammary glands at all eight time points up to
mid-gestation [44]. Mammary glands were digested for 8
h at 37°C in EpiCult-B with 5% fetal bovine serum (FBS),
300 U/ml collagenase and 100 U/ml hyaluronidase. After
vortexing and lysis of the red blood cells in NH4Cl, a sin-
gle cell suspension was obtained by sequential dissocia-
tion of the fragments by gentle pipetting for 1-2 min in
0.25% trypsin, and then 2 min in 5 mg/ml dispase II plus
0.1 mg/ml DNase I (DNase; Sigma Aldrich, St. Louis, MO,
USA) followed by filtration through a 40-μm mesh (BD,
Franklin Lakes, NJ, USA). All reagents were from StemCell
Technologies Inc (Vancouver, BC, Canada) unless other-
wise specified.
The cells were then incubated with a monoclonal anti-
body specific for CD49f (clone GoH3 from Biolegend,
San Diego, CA, USA) that was conjugated to Alexa Fluor-
488. The cells were also incubated with a monoclonal
antibody specific for epithelial cell adhesion molecule
(EpCAM; clone G8.8 from BD) that was previously conju-
gated to Alexa Fluor-647 (Invitrogen). Biotin-conjugated
antibodies specific for CD45, Ter119 and CD31 (clones
30-F11, Ter119 and 390, respectively; all from eBio-
science, San Diego, CA, USA) were used to identify and
exclude contaminating hematopoietic and endothelial
cells. Streptavidin-conjugated phycoerythrin Texas-Red
(Pharmingen) was used to detect biotin conjugated anti-
bodies. Propidium iodide (Sigma) was used at 1 μg/ml for
live/dead cell discrimination. The proportion of luminal,
basal, and stromal cells was determined by analysing the
cells on a CyAn™ ADP (Beckman Coulter, Fullerton, CA,
USA). Stromal, luminal and basal subpopulations were
identified by their CD24-, CD24high  CD49flow  and
CD24low CD49fhigh phenotypes, respectively [44]
MicroRNA in-situ hybridisation
Paraffin embedded mammary gland tissue blocks were
assembled into a tissue microarray including 2-4 cores of
2 mm diameter per sample. Sections of 4 micrometer
thickness were deparaffinized in xylene and rehydrated in
an ethanol dilution series, followed by proteinase K diges-
tion (30 μg/ml for 15 min at 37°C). After refixation in 4%
paraformaldehyde, slides were prehybridised in hybridi-
sation solution (50% formamide, 0.1% Tween, 50 μg/ml
heparin, 5× SSC, 500 μg/ml yeast tRNA, pH 6) at 50-70°C
for 30 min. miRCURY™ LNA-modified DNA oligonucle-
otides complementary to the miRNAs of interest were pur-
chased pre-labelled with digoxigenin at the 5' and 3' ends
(Exiqon Inc., Vedbaek, Denmark). Slides were hybridised
with 100 μl of hybridisation solution containing 5 pmol
of DIG-labelled LNA probe overnight at 50-70°C. After
stringency washes (two rinses in 5 × SSC, followed by 3
washes of 20 min in 50% formamide/2 × SSC at the
hybridisation temperature, with agitation), sections were
rinsed 5 times in PBS/0.1%Tween-20 (PBST), and blocked
for 1 hour in blocking solution (2% sheep serum, 2 mg/
ml BSA in PBST). LNA probes were detected using Roche
horseradish peroxidase-conjugated anti-digoxigenin Fab
fragments (Roche Diagnostics, Mannheim, Germany). An
amplified fluorescent signal was then obtained using the
Perkin-Elmer TSA Plus tyramide signal amplification kit
(Perkin Elmer, MA, USA). For each LNA probe, all images
were obtained from one array slide using the same settings
on a Nikon confocal microscope, and signals were visu-
ally quantified.
MicroRNA expression analysis
MicroRNA isolation and labelling was performed as
described previously [20]. In brief, for each sample small
RNAs (18-26 nucleotides) were recovered from 5 μg total
RNA through denaturing polyacrylamide gel purification,
after spiking in three synthetic pre-labelling control RNAs
to account for target preparation efficiency. Small RNAs
were adaptor-ligated sequentially on the 3'-end and 5'-
end using T4 RNA ligase (Fermentas, Burlington, ONT,
Canada). After reverse-transcription using adaptor-spe-
cific primers, products were PCR-amplified using a bioti-
nylated 5'-primer.
The expression of 318 unique murine miRNAs was deter-
mined using a bead-based flow-cytometric microarray
platform as previously described [20,45]. The platform
was adapted to include 334 probes for 318 unique murine
miRNAs based on the miRNA repository miRBase 9.1 [46]
as well as probes for six artificial control RNAs. In brief,BMC Genomics 2009, 10:548 http://www.biomedcentral.com/1471-2164/10/548
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oligonucleotide capture probes complementary to the
miRNAs of interest were conjugated to colour coded pol-
ystyrene beads (xMAP beads, Luminex Corporation, Aus-
tin, TX, USA) allowing the simultaneous detection of 90
different target miRNAs. To obtain expression profiles for
318 miRNAs, four distinct sets of bead-coupled oligonu-
cleotide probes were created including replicate probes,
and each sample was hybridised to all four bead sets. Sam-
ples were hybridised to probes in solution overnight at
50°C, including technical replicate samples as well as two
water-only blanks and three bead blanks containing water
instead of the labelled sample for use as a background
control. After washing off unbound sample, the sample-
bead solution hybrids were incubated with streptavidin-
phycoerythrin at 50°C for 10 min to detect sample-bound
biotin moieties. Median fluorescence intensity values
were measured on a Luminex 100IS machine using Star-
Station software (ACS, Sheffield, UK).
MicroRNA expression data were submitted to the NCBI
Gene Expression Omnibus http://www.ncbi.nlm.nih.gov/
geo and are available under accession number GSE15057.
Gene expression analysis
Whole genome mRNA expression analysis was performed
using Sentrix Mouse-6 Expression BeadChips V1 (Illu-
mina Inc., San Diego, CA, USA). For each sample, 200 ng
of total RNA were labelled using the Illumina TotalPrep
RNA Amplification Kit according to the manufacturer's
instructions (Applied Biosystems, Foster City, CA, USA).
Labelled samples were hybridised to BeadChips overnight
(18 hours) at 55°C and stringency washes were per-
formed according to the manufacturer's protocol. Data
were acquired using Illumina BeadArray Reader and Bead-
Scan software (Illumina Inc., San Diego, CA, USA).
Gene expression data were submitted to the NCBI Gene
Expression Omnibus http://www.ncbi.nlm.nih.gov/geo
and are available under accession number GSE15057.
Quantitative real-time PCR
Expression of 6 selected miRNAs, including let-7b, let-7g,
miR-1, miR-146, miR-16, and miR-17-5p, was validated
using TaqMan MicroRNA Assays according to the manu-
facturer's instructions (Applied Biosystems, Foster City,
CA, USA) and normalising data to U6 small nuclear RNA
(RNU6; Applied Biosystems) expression. Real-time PCR
reactions and data acquisition were performed on the ABI
Prism 7900HT sequence detection system (Applied Bio-
systems). Details are summarized in Additional file 8.
Expression values of 6 selected genes (mRNA), including
Foxa1, Gata3, Krt14, Krt18, Stat3, and Stat5a, were vali-
dated by quantitative reverse transcription real-time
polymerase chain reaction (qRT-PCR) using custom
designed exon-spanning primers and SYBR Green
reporter, normalising data to the expression values of
beta-actin (Actb) and cyclophilin A (Ppia) as housekeep-
ing genes (Additional data file 2).
Computational data analysis
Preprocessing of miRNA expression data
Median fluorescence intensities smaller than 1 were set
equal to 1 and all values were transformed by taking logs
(base 2). For each sample, two controls spiked into total
extracted RNA were required to exceed a mean intensity of
12 on the log2 scale. 40 out of 57 samples (70%) passed
this quality control. To filter out probes for absent miR-
NAs, each probe was required to exceed 6 on the log2 scale
in all replicate samples for one or more time points. The
criterion was satisfied by 118 probes, corresponding to
102 unique miRNAs. Technical sample effects were esti-
mated by mean relative levels of the two spike-in controls
(one measurement per bead set and control, eight meas-
urements in total) and each sample was normalised by
subtracting the estimated technical effect. Four probes
replicated within and between bead sets and three pairs of
technical replicate samples were summarized by their
mean expression profiles. Biological replicate samples
were summarized by their median expression profiles.
Preprocessing of mRNA expression data
Illumina Mouse v1 gene expression data were processed
and summarized in the Illumina BeadStudio software.
Analysis of the background corrected probe level data was
performed using the beadarray Bioconductor package [47].
Data were transformed by taking logs (base 2) and quan-
tile normalised [48]. Four pairs of technical replicate sam-
ples were summarized by their mean expression profiles.
Biological replicate samples were summarized by their
median expression profiles.
Hierarchical clustering
Hierarchical clustering of median summarized time
points was performed with Pearson correlation and aver-
age linkage. All probes were centred to have mean zero
before clustering.
Clustering of miRNA profiles
Clusters of miRNAs were identified using the MCLUST
package [24]. miRNA profiles over 16 median summa-
rized time points were centred and scaled to have mean
zero and standard deviation one. A multivariate normal
mixture model was fitted to the data, imposing spherical
clusters with identical variance, and allowing for up to 20
mixture components. A model with seven mixture com-
ponents achieved maximal Bayesian Information Crite-
rion.BMC Genomics 2009, 10:548 http://www.biomedcentral.com/1471-2164/10/548
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Breast cancer-associated miRNAs
Human miRNAs associated with basal and luminal breast
cancers were those differentially expressed between 16
basal-like and 15 luminal A samples in [20] (Benjamini-
Hochberg adjusted P  < 0.05, two-sided Wilcoxon rank
sum test). Mouse orthologs were identified based on
sequence identity of the mature miRNA sequence.
Target prediction
Mouse 3' UTR sequences were obtained from the TargetS-
can website (Release 5.1) [49]. The 102 detected miRNAs
were grouped in 65 families with identical seed sequence
(nucleotides 2-8). Since the annotation of many miRNAs
was revised after the beginning of the study (miRBase
Release 9.1), we only considered 58 miRNA families
whose seed sequence was represented among mouse miR-
NAs in miRBase Release 13.0. Targets for individual
miRNA families were defined as genes with at least one
perfect 3' UTR seed match. Targets for a given miRNA clus-
ter were defined as genes with at least one perfect 3' UTR
match to the seed sequence of any of the miRNAs
included in that cluster. For each 3' UTR we calculated the
probability of one or more random matches to the seed
sequence of an individual miRNA family and to those rep-
resented in a given cluster using a compound Poisson
approximation for a second-order Markov model [50].
Target expression
Preprocessed intensities for Illumina probes with unam-
biguous RefSeq annotation for genes with available 3'
UTR information were extracted from the mRNA expres-
sion data. Multiple probes assigned to the same RefSeq ID
were summarized by their mean expression profile. Bio-
logical replicate samples for the same time point were
summarized by their median expression profile, and the
summarized expression profile for each RefSeq gene was
centred to have median zero.
For a given time point and miRNA family, the mean rela-
tive expression of predicted targets was compared to the
mean relative expression of an identical number of con-
trol genes. 100,000 control cohorts were obtained by
drawing an identical number of genes from the pool of all
genes with available 3' UTR information and expression
data, with the probability of an individual gene being
selected proportional to the probability of it containing at
least one seed match (see previous section). We obtained
empirical P-values for reduced expression as the number
of control cohorts with mean expression smaller than or
equal to the one observed. Subsequently P-values were
converted to two-sided P-values. Figure 5 and Additional
file 7 show negative log transformed (base 10) two-sided
P-values for those miRNA families with greatest evidence
for change in the expression of their targets (based on the
minimum observed P-value). The positive and negative y-
axes correspond to increased and reduced expression,
respectively. Dashed lines indicate the threshold for Ben-
jamini-Hochberg corrected P-values smaller than 0.05
(correcting for 58 × 17 = 986 multiple tests).
All analyses were performed using custom Perl scripts and
the statistical programming environment R [51] using
customised functions and functions available from Bio-
conductor [52,53].
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Additional file 1
Cellular composition of mouse mammary glands. Changes in the cellu-
lar composition of the mammary gland are shown for eight developmental 
time points up to mid-gestation. The proportion of luminal, basal, and 
stromal cells was measured by fluorescence-activated cell sorting (FACS) 
of dissociated total mouse mammary glands.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2164-10-548-S1.PDF]
Additional file 2
Validation of gene (mRNA) expression by qRT-PCR. a. Validation of 
selected mRNA genes by qRT-PCR using custom designed primers and 
SYBR Green reporter (left panel), normalising data to the expression val-
ues of housekeeping genes beta-actin (Actb) and cyclophilin A (Ppia) 
(bottom rows). Expression data obtained by Illumina profiling (middle 
panel) showed good correlation with qRT-PCR data (right panel). b. 
Detailed description of SYBR Green qPCR according to MIQE guidelines.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2164-10-548-S2.PDF]BMC Genomics 2009, 10:548 http://www.biomedcentral.com/1471-2164/10/548
Page 13 of 15
(page number not for citation purposes)
Acknowledgements
This study was funded by Cancer Research UK. SAS was funded by a 
research fellowship of the Deutsche Forschungsgemeinschaft DFG (Ger-
many). LDG was supported by an EPSRC fellowship (UK) and by Cancer 
Research UK. JS was supported by the Breast Cancer Campaign (UK). CB 
was supported by the Sirocco EU Framework 6 Integrated Project Grant. 
JLQ was supported by a Cancer Research UK Clinician Scientist Fellowship. 
ST is a Royal Society-Wolfson Research Merit Award holder. We acknowl-
edge the support of The University of Cambridge and Hutchison Whampoa 
Limited. We thank Natalie P. Thorne, Andy Lynch, Gesine Reinert, Sophie 
Schbath and Shamith Samarajiwa for advice and useful discussions on the 
computational analysis.
References
1. Alvarez-Garcia I, Miska EA: MicroRNA functions in animal devel-
opment and human disease.  Development (Cambridge, England)
2005, 132(21):4653-4662.
2. Bartel DP: MicroRNAs: genomics, biogenesis, mechanism,
and function.  Cell 2004, 116(2):281-297.
3. Filipowicz W, Bhattacharyya SN, Sonenberg N: Mechanisms of
post-transcriptional regulation by microRNAs: are the
answers in sight?  Nature Reviews 2008, 9(2):102-114.
4. Baek D, Villen J, Shin C, Camargo FD, Gygi SP, Bartel DP: The
impact of microRNAs on protein output.  Nature 2008,
455(7209):64-71.
5. Selbach M, Schwanhausser B, Thierfelder N, Fang Z, Khanin R, Rajew-
sky N: Widespread changes in protein synthesis induced by
microRNAs.  Nature 2008, 455(7209):58-63.
6. Pillai RS, Bhattacharyya SN, Filipowicz W: Repression of protein
synthesis by miRNAs: how many mechanisms?  Trends in Cell
Biology 2007, 17(3):118-126.
7. Farh KK, Grimson A, Jan C, Lewis BP, Johnston WK, Lim LP, Burge
CB, Bartel DP: The widespread impact of mammalian MicroR-
Additional file 3
Hierarchical clustering of time points based on mRNA expression 
data. Prior to clustering log2 intensities were mean centred across time 
points and multiple probes assigned to the same Entrez ID were summa-
rized by their mean expression profile.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2164-10-548-S3.PDF]
Additional file 4
Enrichment and depletion of GO biological processes (a, b) and 
KEGG pathways (c, d) among predicted miRNA targets. Target genes 
were defined as genes with at least one 3' UTR match to the seed sequence 
of one or more miRNAs in a given cluster (a, c) or to individual seed-iden-
tical miRNA families (b, d). Log2 fold-enrichments are shown as heat-
maps with red and green corresponding to enrichment and depletion, 
respectively. Significance was assessed by a two-sided Fisher's Exact test. 
Shown are gene sets with Benjamini-Hochberg corrected P < 0.01 (out of 
all statistically significant GO terms for a given cluster or miRNA family, 
only the most specific GO terms were included).
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2164-10-548-S4.PDF]
Additional file 5
miRNA expression and genomic location. Heatmap as in main text Fig-
ure 3b with miRNAs in individual clusters reordered according to their 
genomic loci. Brackets in the right-hand margin indicate genomic clusters. 
A mature miRNA was assigned to a genomic cluster if its locus was situ-
ated within 50 kb of another cluster member (genomic clusters in distinct 
regions of the genome that shared a common mature miRNA were 
merged).
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2164-10-548-S5.PDF]
Additional file 6
Higher-magnification images of miRNA in-situ hybridisation. Higher-
magnification images of in-situ hybridisation for miRNAs let-7b, miR-
205, and miR-206, showing higher expression in the epithelial compared 
to the stromal cell compartment, and specificity for the luminal and basal 
epithelial cell layers for let-7b and miR-205, respectively. White scale bars 
in images for time point 25d indicate 100 microns.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2164-10-548-S6.PNG]
Additional file 7
Changes in the expression of predicted miRNA targets. Negative Log10 
transformed two-sided P-values (see Methods) are shown as heatmaps 
with red and green corresponding to evidence for increased and reduced 
relative expression levels, respectively. Target genes were defined as genes 
with at least one 3' UTR match to the seed sequence of one or more miR-
NAs in a given cluster (a) or to individual seed-identical miRNA families 
(b). miRNA families were ordered by the evidence for systematic changes 
in the expression of their targets (based on the minimum observed P-
value). Asterisks indicate Benjamini-Hochberg corrected P < 0.05. (c) 
Greatest evidence for systematic changes in target expression was observed 
for miRNA families miR-29, miR-200bc/429 and let-7/miR-98/1961. 
Dashed lines indicate the threshold for Benjamini-Hochberg corrected P-
values smaller than 0.05.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2164-10-548-S7.PDF]
Additional file 8
Validation of miRNA expression by qRT-PCR. a. Validation of selected 
miRNA genes by qRT-PCR using TaqMan miRNA Assays (left panel). 
qRT-PCR measurements were normalised to U6 small nuclear RNA 
(U6sRNA; bottom row). Expression data obtained by Luminex bead-
based profiling (middle panel) showed good correlation with qRT-PCR 
data (right panel). b. Detailed description of TaqMan qPCR according to 
MIQE guidelines.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2164-10-548-S8.PDF]BMC Genomics 2009, 10:548 http://www.biomedcentral.com/1471-2164/10/548
Page 14 of 15
(page number not for citation purposes)
NAs on mRNA repression and evolution.  Science 2005,
310(5755):1817-1821.
8. Bernstein E, Kim SY, Carmell MA, Murchison EP, Alcorn H, Li MZ,
Mills AA, Elledge SJ, Anderson KV, Hannon GJ: Dicer is essential
for mouse development.  Nat Genet 2003, 35(3):215-217.
9. Miska EA, Alvarez-Saavedra E, Townsend M, Yoshii A, Sestan N, Rakic
P, Constantine-Paton M, Horvitz HR: Microarray analysis of
microRNA expression in the developing mammalian brain.
Genome Biol 2004, 5(9):R68.
10. Zhao Y, Ransom JF, Li A, Vedantham V, von Drehle M, Muth AN,
Tsuchihashi T, McManus MT, Schwartz RJ, Srivastava D: Dysregula-
tion of cardiogenesis, cardiac conduction, and cell cycle in
mice lacking miRNA-1-2.  Cell 2007, 129(2):303-317.
11. Chen CZ, Li L, Lodish HF, Bartel DP: MicroRNAs modulate
hematopoietic lineage differentiation.  Science 2004,
303(5654):83-86.
12. Neilson JR, Zheng GX, Burge CB, Sharp PA: Dynamic regulation
of miRNA expression in ordered stages of cellular develop-
ment.  Genes Dev 2007, 21(5):578-589.
13. Lagos-Quintana M, Rauhut R, Yalcin A, Meyer J, Lendeckel W, Tuschl
T: Identification of tissue-specific microRNAs from mouse.
Curr Biol 2002, 12(9):735-739.
14. Landgraf P, Rusu M, Sheridan R, Sewer A, Iovino N, Aravin A, Pfeffer
S, Rice A, Kamphorst AO, Landthaler M, et al.:  A mammalian
microRNA expression atlas based on small RNA library
sequencing.  Cell 2007, 129(7):1401-1414.
15. Liu CG, Calin GA, Meloon B, Gamliel N, Sevignani C, Ferracin M,
Dumitru CD, Shimizu M, Zupo S, Dono M, et al.: An oligonucle-
otide microchip for genome-wide microRNA profiling in
human and mouse tissues.  P r o c  N a t l  A c a d  S c i  U S A  2004,
101(26):9740-9744.
16. Silveri L, Tilly G, Vilotte JL, Le Provost F: MicroRNA involvement
in mammary gland development and breast cancer.  Repro-
duction, Nutrition, Development 2006, 46(5):549-556.
17. Daniel CW, Silberstein GB: Postnatal development of the
rodent mammary gland.  In The Mammary Gland: Development,
Regulation and Function Edited by: Neville MC, Daniel CW. New York:
Plenum Press Publishing Corp; 1987:3-36. 
18. Hennighausen L, Robinson GW: Information networks in the
mammary gland.  Nat Rev Mol Cell Biol 2005, 6(9):715-725.
19. Sassen S, Miska EA, Caldas C: MicroRNA: implications for can-
cer.  Virchows Arch 2008, 452(1):1-10.
20. Blenkiron C, Goldstein LD, Thorne NP, Spiteri I, Chin SF, Dunning MJ,
Barbosa-Morais NL, Teschendorff AE, Green AR, Ellis IO, et al.:
MicroRNA expression profiling of human breast cancer iden-
tifies new markers of tumour subtype.  Genome Biol 2007,
8(10):R214.
21. Iorio MV, Ferracin M, Liu CG, Veronese A, Spizzo R, Sabbioni S, Magri
E, Pedriali M, Fabbri M, Campiglio M, et al.:  MicroRNA gene
expression deregulation in human breast cancer.  Cancer Res
2005, 65(16):7065-7070.
22. Mattie MD, Benz CC, Bowers J, Sensinger K, Wong L, Scott GK, Fed-
ele V, Ginzinger D, Getts R, Haqq C: Optimized high-throughput
microRNA expression profiling provides novel biomarker
assessment of clinical prostate and breast cancer biopsies.
Molecular Cancer 2006, 5:24.
23. Volinia S, Calin GA, Liu CG, Ambs S, Cimmino A, Petrocca F, Visone
R, Iorio M, Roldo C, Ferracin M, et al.: A microRNA expression
signature of human solid tumors defines cancer gene tar-
gets.  Proc Natl Acad Sci USA 2006, 103(7):2257-2261.
24. Fraley C, Raftery A: Model-based clustering, discriminant anal-
ysis, and density estimation.  J Am Stat Assoc 2002:611-631.
25. Brennecke J, Stark A, Russell RB, Cohen SM: Principles of micro-
RNA-target recognition.  PLoS Biology 2005, 3(3):e85.
26. Grimson A, Farh KK, Johnston WK, Garrett-Engele P, Lim LP, Bartel
DP: MicroRNA targeting specificity in mammals: determi-
nants beyond seed pairing.  Mol Cell 2007, 27(1):91-105.
27. Krek A, Grun D, Poy MN, Wolf R, Rosenberg L, Epstein EJ, MacMe-
namin P, da Piedade I, Gunsalus KC, Stoffel M, et al.: Combinatorial
microRNA target predictions.  Nat Genet 2005, 37(5):495-500.
28. Lewis BP, Burge CB, Bartel DP: Conserved seed pairing, often
flanked by adenosines, indicates that thousands of human
genes are microRNA targets.  Cell 2005, 120(1):15-20.
29. Nielsen CB, Shomron N, Sandberg R, Hornstein E, Kitzman J, Burge
CB: Determinants of targeting by endogenous and exoge-
nous microRNAs and siRNAs.  RNA (New York, NY) 2007,
13(11):1894-1910.
30. Gregory PA, Bert AG, Paterson EL, Barry SC, Tsykin A, Farshid G,
Vadas MA, Khew-Goodall Y, Goodall GJ: The miR-200 family and
miR-205 regulate epithelial to mesenchymal transition by
targeting ZEB1 and SIP1.  Nature Cell Biology 2008,
10(5):593-601.
31. Vallorosi CJ, Day KC, Zhao X, Rashid MG, Rubin MA, Johnson KR,
Wheelock MJ, Day ML: Truncation of the beta-catenin binding
domain of E-cadherin precedes epithelial apoptosis during
prostate and mammary involution.  J Biol Chem 2000,
275(5):3328-3334.
32. Monticelli S, Ansel KM, Xiao C, Socci ND, Krichevsky AM, Thai TH,
Rajewsky N, Marks DS, Sander C, Rajewsky K, et al.: MicroRNA
profiling of the murine hematopoietic system.  Genome Biol
2005, 6(8):R71.
33. Khaled WT, Read EK, Nicholson SE, Baxter FO, Brennan AJ, Came PJ,
Sprigg N, McKenzie AN, Watson CJ: The IL-4/IL-13/Stat6 signal-
ling pathway promotes luminal mammary epithelial cell
development.  Development (Cambridge, England) 2007,
134(15):2739-2750.
34. Clarkson RW, Watson CJ: Microarray analysis of the involution
switch.  Journal of Mammary Gland Biology and Neoplasia 2003,
8(3):309-319.
35. Clarkson RW, Wayland MT, Lee J, Freeman T, Watson CJ: Gene
expression profiling of mammary gland development reveals
putative roles for death receptors and immune mediators in
post-lactational regression.  Breast Cancer Res 2004,
6(2):R92-109.
36. Master SR, Hartman JL, D'Cruz CM, Moody SE, Keiper EA, Ha SI, Cox
JD, Belka GK, Chodosh LA: Functional microarray analysis of
mammary organogenesis reveals a developmental role in
adaptive thermogenesis.  Molecular Endocrinology (Baltimore, Md)
2002, 16(6):1185-1203.
37. Stein T, Salomonis N, Gusterson BA: Mammary gland involution
as a multi-step process.  Journal of Mammary Gland Biology and Neo-
plasia 2007, 12(1):25-35.
38. Ibarra I, Erlich Y, Muthuswamy SK, Sachidanandam R, Hannon GJ: A
role for microRNAs in maintenance of mouse mammary
epithelial progenitor cells.  Genes Dev 2007, 21(24):3238-3243.
39. Yu F, Yao H, Zhu P, Zhang X, Pan Q, Gong C, Huang Y, Hu X, Su F,
Lieberman J, et al.: let-7 regulates self renewal and tumorigenic-
ity of breast cancer cells.  Cell 2007, 131(6):1109-1123.
40. Sempere LF, Christensen M, Silahtaroglu A, Bak M, Heath CV,
Schwartz G, Wells W, Kauppinen S, Cole CN: Altered MicroRNA
expression confined to specific epithelial cell subpopulations
in breast cancer.  Cancer Res 2007, 67(24):11612-11620.
41. Stark A, Brennecke J, Bushati N, Russell RB, Cohen SM: Animal
MicroRNAs confer robustness to gene expression and have a
significant impact on 3'UTR evolution.  Cell 2005,
123(6):1133-1146.
42. Lim LP, Lau NC, Garrett-Engele P, Grimson A, Schelter JM, Castle J,
Bartel DP, Linsley PS, Johnson JM: Microarray analysis shows that
some microRNAs downregulate large numbers of target
mRNAs.  Nature 2005, 433(7027):769-773.
43. Bartel DP: MicroRNAs: target recognition and regulatory
functions.  Cell 2009, 136(2):215-233.
44. Stingl J, Eirew P, Ricketson I, Shackleton M, Vaillant F, Choi D, Li HI,
Eaves CJ: Purification and unique properties of mammary epi-
thelial stem cells.  Nature 2006, 439(7079):993-997.
45. Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, Peck D, Sweet-
Cordero A, Ebert BL, Mak RH, Ferrando AA, et al.: MicroRNA
expression profiles classify human cancers.  Nature 2005,
435(7043):834-838.
46. Griffiths-Jones S, Grocock RJ, van Dongen S, Bateman A, Enright AJ:
miRBase: microRNA sequences, targets and gene nomencla-
ture.  Nucleic Acids Research 2006:D140-144.
47. Dunning MJ, Smith ML, Ritchie ME, Tavare S: beadarray: R classes
and methods for Illumina bead-based data.  Bioinformatics
(Oxford, England) 2007, 23(16):2183-2184.
48. Bolstad BM, Irizarry RA, Astrand M, Speed TP: A comparison of
normalization methods for high density oligonucleotide
array data based on variance and bias.  Bioinformatics (Oxford,
England) 2003, 19(2):185-193.Publish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
BMC Genomics 2009, 10:548 http://www.biomedcentral.com/1471-2164/10/548
Page 15 of 15
(page number not for citation purposes)
49. Friedman RC, Farh KK, Burge CB, Bartel DP: Most mammalian
mRNAs are conserved targets of microRNAs.  Genome
Research 2009, 19(1):92-105.
50. Roquain E, Schbath S: Improved compound Poisson approxima-
tion for the number of occurrences of any rare word family
in a stationary Markov chain.  Advances in Applied Probability 2007,
39:1-13.
51. R Development Core Team.  In A Language and Environment for
Statistical Computing Vienna R Foundation for Statistical Computing;
2003. 
52. Gentleman RC, Carey VJ, Bates DM, Bolstad B, Dettling M, Dudoit S,
Ellis B, Gautier L, Ge Y, Gentry J, et al.: Bioconductor: open soft-
ware development for computational biology and bioinfor-
matics.  Genome Biol 2004, 5(10):R80.
53. Gentleman R, Carey VJ, Huber W, Irizarry RA, Dudoit S: Bioinfor-
matics and Computational Biology Solutions Using R and
Bioconductor.  New York: Springer; 2005. 